Ashland Reports Q2 Results Miss Expectations and Updates Guidance
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 31 2024
0mins
Source: Benzinga
Ashland Inc's stock fell by 10.26% as it crossed below the 5-day SMA, reflecting investor concerns following its Q2 2026 financial results. The company reported a Non-GAAP EPS of $0.91, missing expectations by $0.03, and a slight revenue increase to $482 million, which was below market expectations. Additionally, Ashland revised its fiscal 2026 sales guidance downward, indicating uncertainty in future market conditions and highlighting operational challenges that may affect profitability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ASH?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ASH
Wall Street analysts forecast ASH stock price to rise
9 Analyst Rating
6 Buy
3 Hold
0 Sell
Moderate Buy
Current: 55.990
Low
53.00
Averages
66.67
High
73.00
Current: 55.990
Low
53.00
Averages
66.67
High
73.00
About ASH
Ashland Inc. is a global additives and specialty ingredients company. The Company serves customers in a wide range of consumer and industrial markets, including architectural coatings, construction, energy, food and beverage, personal care and pharmaceuticals. The Company’s segments include Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment consists of pharmaceuticals, nutrition, agricultural chemicals, diagnostic films and fine chemicals. The Personal Care segment includes functionals, microbial protectants (preservatives), skin care, sun care, oral care, hair care and household solutions. The Specialty Additives segment consists of rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive and various industrial markets. The Intermediates segment consists of the production of 1,4 butanediol (BDO) and related derivatives, including n-methyl pyrrolidone.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Securities Fraud Investigation: Pomerantz LLP is investigating whether Ashland Inc. has engaged in securities fraud or other unlawful business practices, which could undermine investor confidence and lead to further stock declines.
- Underperformance Report: In its Q2 2026 results, Ashland reported revenue and non-GAAP earnings per share that fell short of consensus estimates, with CEO Guillermo Novo citing operational challenges at the Hopewell manufacturing facility as a significant factor impacting overall performance.
- Revised Full-Year Guidance: The company updated its full-year sales and EBITDA guidance to reflect productivity challenges associated with the ramp-up at Hopewell, as well as softer energy-related demand due to the Middle East conflict, which may adversely affect future performance.
- Stock Price Plunge: Following the disappointing earnings announcement, Ashland's stock price fell by $7.85, or 13.77%, closing at $49.15 per share on April 29, 2026, indicating market concerns regarding the company's outlook.
See More
- Disappointing Performance: Ashland's Q2 2026 report revealed revenue and non-GAAP EPS falling short of consensus estimates, indicating operational challenges that may undermine investor confidence.
- Operational Challenges: CEO Guillermo Novo highlighted that specific difficulties at the Hopewell manufacturing facility negatively impacted overall results, reflecting issues encountered during the company's scaling efforts.
- Revised Full-Year Guidance: Ashland updated its full-year sales and EBITDA guidance due to productivity challenges at Hopewell and softer energy-related demand stemming from the Middle East conflict, indicating a tough market environment.
- Significant Stock Drop: Following the disappointing results, Ashland's stock price plummeted by $7.85, or 13.77%, closing at $49.15 per share on April 29, 2026, reflecting market concerns about the company's outlook.
See More

- Investigation Launched: The Schall Law Firm has initiated an investigation into Ashland Inc. regarding potential violations of securities laws, focusing on whether the company made false or misleading statements that could affect investors' rights.
- Earnings Miss: In its Q2 2026 financial report, Ashland reported revenues and earnings per share that fell short of analyst expectations, with the CEO attributing the disappointing results to specific operational challenges, highlighting the pressures the company is facing.
- Guidance Downgrade: The company has revised its full-year guidance to reflect productivity issues associated with the ramp-up at its Hopewell facility, as well as softer energy-related demand due to the Middle East conflict, raising further concerns about its future performance.
- Severe Stock Reaction: Following the earnings miss and investigation news, Ashland's shares plummeted nearly 13.8% the next day, indicating a significant decline in investor confidence regarding the company's outlook.
See More
- LCI Industries Upgrade: Roth upgrades LCI Industries from Hold to Buy with a price target of $164, unchanged, following outsized Q1 EPS, indicating strong profitability that is expected to drive stock price upward.
- VF Corp Upgrade: BTIG raises VF Corp's rating from Neutral to Buy, citing more reasonable estimates reflecting positive outlook for Vans brand, which could enhance market confidence and shareholder returns.
- DaVita's Strong Performance: Deutsche Bank upgrades DaVita from Hold to Buy after reporting Q1 revenues of $3.415 billion, beating consensus by 2.2%, and EPS of $2.87, exceeding expectations by 22.1%, showcasing robust treatment growth and revenue per treatment.
- Monster Beverage Upgrade: Rothschild & Co Redburn upgrades Monster Beverage from Neutral to Buy, highlighting significant international growth potential as the company currently holds only 14% market share, suggesting substantial future market position improvement.
See More
- Dividend Increase: Ashland Inc. has declared a quarterly cash dividend of $0.42 per share, reflecting a 1.2% increase from the previous quarter, which demonstrates the company's ongoing commitment to maintaining profitability and enhancing investor confidence.
- Payment Date: The dividend will be payable on June 15, 2026, to shareholders of record as of June 1, 2026, ensuring a timely cash inflow for investors and further increasing the company's attractiveness.
- Share Outstanding: As of April 30, 2026, there are 45,788,007 shares of Ashland common stock outstanding, indicating a stable equity structure that provides a solid capital foundation to support future growth strategies.
- Company Overview: Ashland Inc. is a global additives and specialty ingredients company with a proactive approach to environmental, social, and governance (ESG) practices, serving diverse industries such as architectural coatings, energy, and food and beverage, showcasing its competitive advantage in various markets.
See More
- Dividend Growth Expectation: Ashland is expected to announce a dividend increase this May, continuing its 16-year streak of regular growth, with analysts predicting an annual dividend of approximately $1.70 per share, translating to a quarterly dividend of about $0.425, which represents a 2.4% increase from last year's $0.415.
- Dividend Quality Metrics: The company exhibits strong dividend quality metrics, with a safety rating of C+, a growth rating of D, a yield rating of B, and an A for consistency, indicating its reliability and stability in dividend payments.
- Financial Performance Issues: Despite the optimistic dividend growth outlook, Ashland's Q2 2026 earnings report revealed a non-GAAP EPS of $0.91, missing expectations by $0.03, and revenue of $482 million fell short by $3.61 million, highlighting the profitability challenges the company faces.
- Future Outlook: Ashland forecasts fiscal 2026 sales between $1.835 billion and $1.87 billion, with adjusted EBITDA projected at $385 million to $400 million, although timing cuts from Hopewell are expected to reduce savings by $10 million to $12 million, the company remains focused on achieving long-term growth objectives.
See More








